サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1514239

心臓リズム管理（CRM）機器の世界市場

Cardiac Rhythm Management (CRM) Devices

出版日
ページ情報
英文 274 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
心臓リズム管理（CRM）機器の世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 274 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

心臓リズム管理（CRM）機器の世界市場は2030年までに239億米ドルに達する見込み

2023年に185億米ドルと推定される心臓リズム管理（CRM）機器の世界市場は、2023年から2030年にかけてCAGR 3.8%で成長し、2030年には239億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである除細動器は、CAGR 4.4%を記録し、分析期間終了時には113億米ドルに達すると予測されます。ペースメーカー分野の成長率は、分析期間でCAGR 3.6％と推定されます。

米国市場は推定50億米ドル、中国はCAGR6.6%で成長予測

米国の心臓リズム管理（CRM）機器市場は2023年に50億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに50億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは6.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.9%と4.4%と予測されています。欧州では、ドイツがCAGR 1.8%で成長すると予測されています。

世界の心臓リズム管理（CRM）機器市場- 主要動向と促進要因のまとめ

心臓リズム管理（CRM）機器は、不規則な心拍リズムやその他の関連する心臓疾患の診断と治療のために、医療分野で極めて重要な役割を担っています。これらのデバイスには、ペースメーカー、植え込み型除細動器（ICD）、心臓再同期療法（CRT）デバイスなど、適切な心臓機能を確保するために設計された多様な製品が含まれます。ペースメーカーは主に、一定の心拍を刺激する電気インパルスを送ることによって徐脈を管理するために使用されます。一方、ICDは心臓のリズムを継続的に監視し、重度の不整脈や突然の心停止のエピソード中に救命のためのショックを与えて正常なリズムを回復させる。CRTは、心室の収縮を調整し、各心拍の効率を向上させるため、心不全患者にとって特に有益です。CRM機器では、リード線（針金）を不要とし、感染リスクや手技合併症を軽減するリードレス・ペースメーカーの開発など、大幅な技術進歩が見られます。さらに、MRIに対応したCRM装置も登場し、従来は禁忌とされていた磁気共鳴イメージングを安全に受けることができるようになりました。

CRM機器の市場は、心血管疾患の有病率の上昇と、高度な診断・治療技術の採用増加により、大きな成長を遂げています。心血管疾患は依然として世界の死亡の主要原因の一つであり、何百万人もの人々に影響を与え、効果的な管理ソリューションに対する大きな需要を生み出しています。心臓疾患に罹患しやすい世界人口の高齢化は、CRM機器の必要性をさらに高めています。さらに、CRM機器にリモート・モニタリング・システムを統合することで、心臓リズムの継続的なリアルタイム・モニタリングが可能になり、タイムリーな医療介入が容易になるため、患者ケアに革命的な変化をもたらしました。このような遠隔システムは、潜在的な問題を早期に発見することで、患者の予後を改善するだけでなく、頻繁な通院や再入院の必要性を減らし、最終的には医療費を削減します。ヘルスケアのプロバイダーは、ケアの質を高めるために、このような高度なCRM機器を採用するようになってきています。さらに、先進国市場と新興国市場の両方における有利な償還政策と医療費の増加が、さまざまな医療環境におけるCRM機器の採用を後押ししています。

CRM機器市場の成長は、技術の進歩、心血管疾患の罹患率の上昇、低侵襲処置への嗜好の高まりなど、いくつかの要因によって牽引されています。ワイヤレスCRM機器や人工知能の統合などの技術革新により、CRM機器の機能性と患者の利便性が大幅に向上し、採用が増加しています。リードレスペースメーカーやMRI対応機器の市場開拓は、患者により安全で汎用性の高い選択肢を提供することで、対応可能な市場を拡大しました。心血管疾患の有病率の増加と高齢化により、効果的な管理ツールとしてのCRM機器への需要が高まっています。さらに、外来処置や在宅ケアモデルへのシフトが、ポータブルで遠隔モニタリング可能なCRM機器への需要を押し上げています。規制当局の承認や基準も、これらの機器の安全性と有効性を保証し、市場導入の推進に重要な役割を果たしています。さらに、新興市場におけるヘルスケア・インフラの拡大や心臓ケア施設に対する投資の増加は、高度なCRM技術をより幅広い患者層が利用できるようにし、新たな成長機会を生み出しています。革新的で効果的な心臓ケアソリューションに対するニーズの高まりを反映し、CRM機器市場の堅調な成長軌道を裏付けています。

調査対象企業の例（全34件）

  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medtronic, Inc.
  • Physio-Control, Inc.
  • Schiller AG
  • ZOLL Medical Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-6132

Global Cardiac Rhythm Management (CRM) Devices Market to Reach US$23.9 Billion by 2030

The global market for Cardiac Rhythm Management (CRM) Devices estimated at US$18.5 Billion in the year 2023, is expected to reach US$23.9 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Defibrillators, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$11.3 Billion by the end of the analysis period. Growth in the Pacemakers segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.0 Billion While China is Forecast to Grow at 6.6% CAGR

The Cardiac Rhythm Management (CRM) Devices market in the U.S. is estimated at US$5.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.0 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Cardiac Rhythm Management (CRM) Devices Market - Key Trends and Drivers Summarized

Cardiac Rhythm Management (CRM) devices are crucial in the medical field for diagnosing and treating irregular heart rhythms and other related cardiac conditions. These devices include a diverse array of products such as pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices, all designed to ensure proper heart function. Pacemakers are primarily used to manage bradycardia by sending electrical impulses to stimulate a consistent heartbeat. ICDs, on the other hand, continuously monitor heart rhythms and deliver life-saving shocks to restore normal rhythm during episodes of severe arrhythmias or sudden cardiac arrest. CRT devices are particularly beneficial for patients with heart failure, as they coordinate the contractions of the heart's ventricles, improving the efficiency of each heartbeat. The CRM device landscape has seen substantial technological advancements, such as the development of leadless pacemakers, which eliminate the need for leads (wires) and thereby reduce infection risks and procedural complications. Additionally, MRI-compatible CRM devices have emerged, allowing patients with these implants to safely undergo magnetic resonance imaging, which was previously contraindicated.

The market for CRM devices is experiencing significant growth driven by the rising prevalence of cardiovascular diseases and the increasing adoption of advanced diagnostic and therapeutic technologies. Cardiovascular diseases remain one of the leading causes of mortality worldwide, affecting millions of people and creating a substantial demand for effective management solutions. The aging global population, which is more susceptible to cardiac conditions, further drives the need for CRM devices. Moreover, the integration of remote monitoring systems in CRM devices has revolutionized patient care by enabling continuous, real-time monitoring of heart rhythms, thereby facilitating timely medical interventions. These remote systems not only improve patient outcomes by providing early detection of potential issues but also reduce the need for frequent hospital visits and readmissions, ultimately lowering healthcare costs. Healthcare providers are increasingly adopting these advanced CRM devices to enhance the quality of care. Additionally, favorable reimbursement policies and growing healthcare expenditure in both developed and emerging markets are bolstering the adoption of CRM devices across various healthcare settings.

The growth in the CRM devices market is driven by several factors, including technological advancements, the rising incidence of cardiovascular diseases, and the growing preference for minimally invasive procedures. Technological innovations, such as wireless CRM devices and the integration of artificial intelligence, have significantly enhanced the functionality and patient-friendliness of these devices, leading to increased adoption. The development of leadless pacemakers and MRI-compatible devices has expanded the addressable market by offering safer and more versatile options for patients. The increasing prevalence of cardiovascular diseases, coupled with an aging population, has heightened the demand for CRM devices as effective management tools. Moreover, the shift towards outpatient procedures and home-based care models has driven the demand for portable and remotely monitored CRM devices. Regulatory approvals and standards have also played a crucial role in propelling market adoption, ensuring the safety and efficacy of these devices. Furthermore, the expansion of healthcare infrastructure in emerging markets and rising investments in cardiac care facilities have generated new growth opportunities, making advanced CRM technologies more accessible to a broader patient population. These factors collectively underscore the robust growth trajectory of the CRM devices market, reflecting the increasing need for innovative and effective cardiac care solutions.

Select Competitors (Total 34 Featured) -

  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medtronic, Inc.
  • Physio-Control, Inc.
  • Schiller AG
  • ZOLL Medical Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cardiac Rhythm Management (CRM) Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cardiovascular Diseases Spurs Demand for CRM Devices
    • Advances in Wireless CRM Technologies Propel Growth
    • Increasing Adoption of Remote Monitoring Systems Strengthens Business Case for CRM Devices
    • Technological Innovations in Leadless Pacemakers Expand Addressable Market Opportunity
    • Growing Awareness and Early Diagnosis of Cardiac Disorders Drive Market Adoption
    • Integration of AI in CRM Devices Generates Demand
    • Rising Healthcare Expenditure Sustains Market Growth
    • Aging Population and Associated Cardiac Conditions Propel Growth in CRM Device Utilization
    • Development of MRI-Compatible CRM Devices Expands Addressable Market
    • Increasing Investments in Cardiac Care Facilities Generate Opportunities for Market Expansion
    • Shift Towards Outpatient Procedures Spurs Growth in CRM Devices Market
    • Innovations in Battery Life and Device Longevity Strengthen Business Case for Adoption
    • Growing Use of CRM Devices in Emerging Economies Expands Addressable Market Opportunity
    • Focus on Reducing Hospital Readmissions Generates Demand for Advanced CRM Solutions
    • Rising Number of Cardiac Rehabilitation Programs Strengthens Business Case for CRM Devices
    • Focus on Personalized Medicine and Tailored Cardiac Treatments Drives Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiac Rhythm Management (CRM) Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cardiac Rhythm Management (CRM) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Defibrillators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Defibrillators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pacemakers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Pacemakers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cardiac Resynchronization Therapy (CRT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Cardiac Rhythm Management (CRM) Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • INDIA
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030
  • AFRICA
    • Cardiac Rhythm Management (CRM) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Cardiac Rhythm Management (CRM) Devices by Product Type - Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Cardiac Rhythm Management (CRM) Devices by Product Type - Percentage Breakdown of Value Sales for Defibrillators, Pacemakers and Cardiac Resynchronization Therapy (CRT) for the Years 2014, 2024 & 2030

IV. COMPETITION